Refractory ventricular tachycardia/fibrillation is one of the common causes of cardiac arrest. Mortality and morbidity are significantly high for cardiac arrests associated with refractory ventricular tachyarrhythmias. Current ACLS guidelines recommend pharmacological treatment with either amiodarone or lidocaine. Controversy exists on whether amiodarone or lidocaine is a better antiarrhythmic choice in the cardiac arrest setting. Additionally, there is very limited data on use of other antiarrhythmic medications for refractory ventricular tachyarrhythmias for patients who either fail amiodarone and lidocaine. This presentation will examine a few studies comparing the efficacy and safety of different antiarrhythmics for the treatment of refractory ventricular tachycardia/fibrillation.
- Provider:Ascension
- Activity Link: https://ascension-ce-cme.cloud-cme.com
- Start Date: 2024-03-08 06:00:00
- End Date: 2024-03-08 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Limited